IGFBP3 and Cachexia: Not only local IGFBP-3 synthetized in skeletal muscle can be associated with muscle wasting and cachexia in sepsis or in other inflammatory diseases, but also an excess of systemic IGFBP-3 can contribute to muscle atrophy.